EMAIL THIS PAGE TO A FRIEND

Gene therapy

Gene delivery to the spinal cord using MRI-guided focused ultrasound.


PMID 25781651

Abstract

Non-invasive gene delivery across the blood-spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease. Here, we demonstrate the use of magnetic resonance image-guided focused ultrasound (MRIgFUS) to mediate non-surgical gene delivery to the spinal cord using self-complementary adeno-associated virus serotype 9 (scAAV9). scAAV9 encoding green fluorescent protein (GFP) was injected intravenously in rats at three dosages: 4 × 10(8), 2 × 10(9) and 7 × 10(9) vector genomes per gram (VG g(-1)). MRIgFUS allowed for transient, targeted permeabilization of the BSCB through the interaction of focused ultrasound (FUS) with systemically injected Definity lipid-shelled microbubbles. Viral delivery at 2 × 10(9) and 7 × 10(9) VG g(-1) leads to robust GFP expression in FUS-targeted regions of the spinal cord. At a dose of 2 × 10(9) VG g(-1), GFP expression was found in 36% of oligodendrocytes, and in 87% of neurons in FUS-treated areas. FUS applications to the spinal cord could address a long-term goal of gene therapy: delivering vectors from the circulation to diseased areas in a non-invasive manner.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D27802
1,4-Diazabicyclo[2.2.2]octane, ReagentPlus®, ≥99%
C6H12N2
D2522
1,4-Diazabicyclo[2.2.2]octane
C6H12N2
C3032
Cesium chloride, for molecular biology, ≥99% (silver nitrate titration)
ClCs
C4036
Cesium chloride, for molecular biology, ≥98%
ClCs
C3139
Cesium chloride, optical grade, ≥99.5% trace metals basis
ClCs
203025
Cesium chloride, ≥99.999% trace metals basis
ClCs
C3011
Cesium chloride, Grade I, ≥99.0%
ClCs
20966
Cesium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
ClCs
562599
Cesium chloride, 99.99% trace metals basis
ClCs
C6914
Cesium chloride, Grade II, ≥98%
ClCs
C3309
Cesium chloride, BioXtra, ≥99.5% (titration)
ClCs
449733
Cesium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
ClCs
290734
Dabco® 33-LV
C6H12N2
T1378
Sigma 7-9®, ≥99% (titration), crystalline
C4H11NO3
252859
Tris(hydroxymethyl)aminomethane, ACS reagent, ≥99.8%
C4H11NO3
T1503
Trizma® base, Primary Standard and Buffer, ≥99.9% (titration), crystalline
C4H11NO3
T6066
Trizma® base, BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)
C4H11NO3
93362
Trizma® base, BioUltra, for molecular biology, ≥99.8% (T)
C4H11NO3
T6791
Trizma® base, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
C4H11NO3
T4661
Trizma® base, ≥99.9% (titration), crystalline
C4H11NO3
93352
Trizma® base, ≥99.0% (T)
C4H11NO3
RDD008
Trizma® base, anhydrous, free-flowing, Redi-Dri, ≥99.9%
C4H11NO3
93350
Trizma® base, puriss. p.a., ≥99.7% (T)
C4H11NO3
T6687
Tromethamine, meets USP testing specifications
C4H11NO3
RES3193T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture, Meets USP, EP, JPC, BP testing specifications.
C4H11NO3